Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins

BACKGROUND: Cancer cell resistance to therapeutics can result from acquired or de novo-mediated factors. Here, we have utilised advanced breast cancer cell culture models to elucidate de novo doxorubicin resistance mechanisms. METHODS: The response of breast cancer cell lines (MCF-7 and MDA-MB-231)...

Descripción completa

Detalles Bibliográficos
Autores principales: Lovitt, Carrie J., Shelper, Todd B., Avery, Vicky M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756400/
https://www.ncbi.nlm.nih.gov/pubmed/29304770
http://dx.doi.org/10.1186/s12885-017-3953-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756400/
https://www.ncbi.nlm.nih.gov/pubmed/29304770
http://dx.doi.org/10.1186/s12885-017-3953-6

Ejemplares similares